Acute Promyelocytic Leukemia News and Research

RSS
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) and is characterized by a unique molecular abnormality. This type of leukemia has a high mortality rate and is associated with early hemorrhagic death.
CytRx announces its plans to advance multiple oncology development programs in 2010

CytRx announces its plans to advance multiple oncology development programs in 2010

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

New treatment options for leukemia and myeloproliferative disorders introduced

New treatment options for leukemia and myeloproliferative disorders introduced

CytRx reports financial results for the three months and nine months ended September 30, 2009

CytRx reports financial results for the three months and nine months ended September 30, 2009

NCCN Guidelines for Acute Myeloid Leukemia updated

NCCN Guidelines for Acute Myeloid Leukemia updated

Cytrx initiates tamibarotene and TRISENOX combination dose escalation study

Cytrx initiates tamibarotene and TRISENOX combination dose escalation study

Targeted nanoparticles boost arsenic’s anticancer punch

Targeted nanoparticles boost arsenic’s anticancer punch

Arsenic-based agent shown to help eradicate leukemia-initiating cells

Arsenic-based agent shown to help eradicate leukemia-initiating cells

FDA grants orphan drug designation to TREANDA

FDA grants orphan drug designation to TREANDA

New insights into acute promyelocytic leukemia

New insights into acute promyelocytic leukemia

Arsenic trioxide shows survival benefit for leukemia patients

Arsenic trioxide shows survival benefit for leukemia patients

Translocation kidney cancer after chemotherapy in childhood

Translocation kidney cancer after chemotherapy in childhood

Cell Therapeutics settles law suit with Government

Cell Therapeutics settles law suit with Government

Gene used in brain development can cause childhood brain cancers

Gene used in brain development can cause childhood brain cancers

Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

A biological agent used without chemotherapy appears to offer a disease-free future to patients with rare leukemia

A biological agent used without chemotherapy appears to offer a disease-free future to patients with rare leukemia